Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on October 1, 2026

2 hours ago

NMDP Gala Highlights Financial Challenges Facing Patients in Need of Blood Stem Cell Transplants

Indeterminate GlobeNewswire

2 hours ago

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)

Indeterminate GlobeNewswire

2 hours ago

FDA Grants Fast Track Designation for TRE-515 in Combination with KRAS G12C Inhibitors for the Treatment of Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

2 hours ago

Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss 

Indeterminate GlobeNewswire

2 hours ago

Bloom Healthcare Brings Its Proven In-Home Care Model to Dallas-Fort Worth Seniors

Indeterminate GlobeNewswire

3 hours ago

Michigan Contact Lens Opens 1-800-DRY-EYES Center in Expanded Southfield Facility

Indeterminate GlobeNewswire

3 hours ago

Government of Saskatchewan proclaims October Health Literacy Month

Indeterminate GlobeNewswire

3 hours ago

Advocates From Across the Nation Meet With Federal Lawmakers to Champion Mental Health Clubhouses

Indeterminate GlobeNewswire

3 hours ago

HealthEdge Launches Unified AI-Powered Platform to Guarantee Financial Outcomes for Health Plans 

Indeterminate GlobeNewswire

4 hours ago

Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients

Indeterminate GlobeNewswire

4 hours ago

AI Is Reshaping Gene Transfer Technologies — $258.7 Billion in VC Signals a Structural Shift in Biotech Investment

Indeterminate GlobeNewswire

4 hours ago

Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts

Indeterminate GlobeNewswire

4 hours ago

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Indeterminate GlobeNewswire

4 hours ago

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Indeterminate GlobeNewswire

4 hours ago

Crohn’s and Colitis Canada Invests $1.5 Million to Advance IBD Research and Future Care

Indeterminate GlobeNewswire

4 hours ago

Crohn et Colite Canada investit 1,5 million de dollars dans la recherche sur les MII et les soins futurs

Indeterminate GlobeNewswire

4 hours ago

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

Indeterminate GlobeNewswire

4 hours ago

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

Indeterminate GlobeNewswire

4 hours ago

Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities

Indeterminate GlobeNewswire

4 hours ago

American Kidney Fund and IgA Nephropathy Foundation Advocate on Capitol Hill for Rare Kidney Disease Legislation

Indeterminate GlobeNewswire